Anxiety Disorders
Conditions
Interventions
This is a three-arm, single-blind, randomized controlled trial. Volunteers will be randomly allocated via the website (www.randomizer.org) into: tDCS group (Transcranial Direct Current Stimulation), t
E02.331.800
Sponsors
Instituto de Saúde e Biotecnologia
Instituto de Saúde e Biotecnologia
Eligibility
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: be aged between 18 and 40, of both sexes, be a university student at ISB/UFAM, have a clinical diagnosis, according to the criteria of the American Psychiatric Association 5th edition - DSM-V (2014), of anxiety disorders, and cognitive ability to understand the purpose of the research and to answer the scales and questionnaires
Exclusion criteria
Exclusion criteria: conditions such as uncontrolled epilepsy, individuals with metallic intracranial implants near the electrodes, pregnant women, history of brain surgery, tumor and undergoing psychotherapy at the time of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We hope to find an improvement in anxiety levels in volunteers undergoing non-invasive neuromodulation in the tDCS or tVNS modalities. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactWilliam Leite
Instituto de Saúde e Biotecnologia
Outcome results
None listed